EFA
XTNT icon

Evernest Financial Advisors’s Xtant Medical Holdings XTNT Stock Holding History

Evernest Financial Advisors’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40,000
Closed -$27K – 181
2024
Q3 		$27K Buy
+40,000
New +$26.4K 0.01% 162

Other funds holding XTNT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Evernest Financial Advisors's XTNT Position: Q4 2024 in Review

Evernest Financial Advisors sold out of Xtant Medical Holdings (XTNT) in Q4 2024, closing a stake of 40,000 shares — an estimated $27K sold.

Evernest Financial Advisors first reported a position in XTNT in Q3 2024 and held it in 1 quarter. The position peaked at $27K in Q3 2024. 30 funds tracked by Wall St. Rank hold XTNT as of Q4 2024.

  • Evernest Financial Advisors reported no remaining Xtant Medical Holdings position as of Q4 2024 after selling out during the quarter.
  • Evernest Financial Advisors sold 40,000 Xtant Medical Holdings shares in Q4 2024, an estimated $27K.
  • Evernest Financial Advisors first reported a position in Xtant Medical Holdings in Q3 2024 and held it in 1 quarter.
  • Evernest Financial Advisors's Xtant Medical Holdings position peaked at $27K in Q3 2024.
  • 30 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q4 2024.

Based on Evernest Financial Advisors's 13F filing for Q4 2024, filed 23 Jan 2025.